Fml-Neo Liquifilm Ophthalmic Suspension 1,0 mg/ml Ophthalmic suspension
PDF Leaflet Revision Date: 03 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infectious conjunctivitis and anterior segment inflammatory disorders.
Dosage (summary)
1-2 drops in the conjunctival sac 2-4 times daily; may increase to 1 drop hourly for the first 24-48 hours.
Special Populations
- Elderly
- Children under 2 years
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; potential reproductive toxicity.
Key Drug Interactions
- CYP3A inhibitors may increase systemic corticosteroid effects
Contraindications
- Hypersensitivity to ingredients
- Acute untreated purulent infections
- Herpes simplex keratitis
- Fungal ocular diseases
- Ocular tuberculosis
- Glaucoma
Common side effects
- Increased intraocular pressure
- Eye irritation
- Blurred vision
- Eye pain
- Hypersensitivity
Counselling Points
- Complete the full course of treatment.
- Avoid touching the bottle tip to any surface.
- Remove contact lenses before use and wait 15 minutes to reinsert.
Serious warnings
- Prolonged use may increase intraocular pressure and risk of glaucoma.
- Use under strict supervision if longer than one week.
Important Disclaimer
The Fml-Neo Liquifilm Ophthalmic Suspension 1,0 mg/ml Ophthalmic suspension professional information leaflet below is the property of AbbVie and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
